Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese population.

Cancer letters - 28 Jul 2005

Zhenhua Li, Tsuchiya Norihiko, Narita Shintaro, Inoue Takamitsu, Horikawa Yohei, Kakinuma Hideaki, Kato Tetsuro, Ogawa Osamu, Habuchi Tomonori

Abstract excerpt

The CYP3A5 gene (CYP3A5) encodes the cytochrome P450 3A5, which catalyzes the 6beta-hydroxylation of testosterone. We explored association between the CYP3A5 A6986G polymorphism and a risk of prostate cancer in 260 prostate cancer patients, 199 BPH patients and 212 male controls. The CYP3A5 gene polymorphism did not influence significantly a risk of developing of prostate cancer in general. However, compared with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cytochrome P-450 CYP3A

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 Enzyme System

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Polymorphism, Genetic

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 15876487
DOI: 10.1016/j.canlet.2005.03.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese population.PMID 15876487Read ↗

Association of CYP3A5*3 polymorphisms and prostate cancer risk: A meta-analysis.Semantic proximity Read ↗

Genetic association in CYP3A4 and CYP3A5 genes elevate the risk of prostate cancer.Semantic proximity Read ↗

CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer.Semantic proximity Read ↗

Association between the CYP3A4 and CYP3A5 polymorphisms and cancer risk: a meta-analysis and meta-regression.Semantic proximity Read ↗

The interaction of CYP3A5 polymorphisms along the androgen metabolism pathway in prostate cancer.Semantic proximity Read ↗

Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population.Semantic proximity Read ↗

Cyclooxygenase 2 genotypes influence prostate cancer susceptibility in Japanese Men.Semantic proximity Read ↗

Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population.Semantic proximity Read ↗

Meta-analysis of three polymorphisms in the steroid-5-alpha-reductase, alpha polypeptide 2 gene (SRD5A2) and risk of prostate cancer.Semantic proximity Read ↗

Lack of association between methylenetetrahydrofolate dehydrogenase 1 G1958A polymorphism and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer.Semantic proximity Read ↗

The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.